200 related articles for article (PubMed ID: 23613724)
21. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.
Hageman GS; Hancox LS; Taiber AJ; Gehrs KM; Anderson DH; Johnson LV; Radeke MJ; Kavanagh D; Richards A; Atkinson J; Meri S; Bergeron J; Zernant J; Merriam J; Gold B; Allikmets R; Dean M;
Ann Med; 2006; 38(8):592-604. PubMed ID: 17438673
[TBL] [Abstract][Full Text] [Related]
22. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
[TBL] [Abstract][Full Text] [Related]
23. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.
Francis NJ; McNicholas B; Awan A; Waldron M; Reddan D; Sadlier D; Kavanagh D; Strain L; Marchbank KJ; Harris CL; Goodship TH
Blood; 2012 Jan; 119(2):591-601. PubMed ID: 22058112
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of CFH Y402H polymorphism and CFHR3/CFHR1 deletion in age-related macular degeneration patients from Brazil.
Dezidério Sacconi DP; Cabral de Vasconcellos JP; Endo Hirata F; MacCord Medina F; Rim PH; Barbosa de Melo M
Ophthalmic Genet; 2016 Dec; 37(4):459-461. PubMed ID: 26942649
[No Abstract] [Full Text] [Related]
25. A genome-wide association study identifies key modulators of complement factor H binding to malondialdehyde-epitopes.
Alic L; Papac-Milicevic N; Czamara D; Rudnick RB; Ozsvar-Kozma M; Hartmann A; Gurbisz M; Hoermann G; Haslinger-Hutter S; Zipfel PF; Skerka C; Binder EB; Binder CJ
Proc Natl Acad Sci U S A; 2020 May; 117(18):9942-9951. PubMed ID: 32321835
[TBL] [Abstract][Full Text] [Related]
26. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
[TBL] [Abstract][Full Text] [Related]
27. Carfilzomib-induced aHUS responds to early eculizumab and may be associated with heterozygous
Portuguese AJ; Lipe B
Blood Adv; 2018 Dec; 2(23):3443-3446. PubMed ID: 30518536
[TBL] [Abstract][Full Text] [Related]
28. Chronic course of a hemolytic uremic syndrome caused by a deficiency of factor H-related proteins (CFHR1 and CFHR3).
Koziolek MJ; Zipfel PF; Skerka C; Vasko R; Gröne EF; Müller GA; Strutz F
Kidney Int; 2008 Aug; 74(3):384-8. PubMed ID: 18449173
[No Abstract] [Full Text] [Related]
29. Copy number polymorphisms in new HapMap III and Singapore populations.
Ku CS; Teo SM; Naidoo N; Sim X; Teo YY; Pawitan Y; Seielstad M; Chia KS; Salim A
J Hum Genet; 2011 Aug; 56(8):552-60. PubMed ID: 21677662
[TBL] [Abstract][Full Text] [Related]
30. A Heterozygous CFHR3-CFHR1 Gene Deletion in a Pediatric Patient With Transplant-associated Thrombotic Microangiopathy Who was Treated With Eculizumab.
Nozawa A; Ozeki M; Hori T; Kawamoto N; Hirayama M; Azuma E; Fukao T
J Pediatr Hematol Oncol; 2018 Nov; 40(8):e544-e546. PubMed ID: 28991129
[TBL] [Abstract][Full Text] [Related]
31. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implications.
Hageman GS; Hancox LS; Taiber AJ; Gehrs KM; Anderson DH; Johnson LV; Radeke MJ; Kavanagh D; Richards A; Atkinson J; Meri S; Bergeron J; Zernant J; Merriam J; Gold B; Allikmets R; Dean M
Ann Med; 2006; 38(8):592-604. PubMed ID: 28950782
[TBL] [Abstract][Full Text] [Related]
32. The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases.
Hamza A; El-Sissy C; Yousfi N; Martins PV; Rafat C; Masliah-Planchon J; Frémeaux-Bacchi V; Mesnard L
Eur J Hum Genet; 2023 Jul; 31(7):730-732. PubMed ID: 37032353
[No Abstract] [Full Text] [Related]
33. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
de Holanda MI; Pôrto LC; Wagner T; Christiani LF; Palma LMP
Clin Rheumatol; 2017 Dec; 36(12):2859-2867. PubMed ID: 28905254
[TBL] [Abstract][Full Text] [Related]
34. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.
Grenda R; Jarmużek W; Rubik J; Prokurat S; Miklaszewska M; Drozdz D; Zachwieja K; Ardissino G; Hofer J
Pediatr Transplant; 2015 Sep; 19(6):E130-4. PubMed ID: 26087050
[TBL] [Abstract][Full Text] [Related]
35. [Study on the CFHR1 level and its genetic polymorphisms in type 2 diabetes mellitus patients].
Wang J; Yu W; Xu J; Feng L; Liu X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Jun; 34(3):438-442. PubMed ID: 28604974
[TBL] [Abstract][Full Text] [Related]
36. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.
Józsi M; Licht C; Strobel S; Zipfel SL; Richter H; Heinen S; Zipfel PF; Skerka C
Blood; 2008 Feb; 111(3):1512-4. PubMed ID: 18006700
[TBL] [Abstract][Full Text] [Related]
37. Association assessment of copy number polymorphism and risk of age-related macular degeneration.
Sawitzke J; Im KM; Kostiha B; Dean M; Gold B
Ophthalmology; 2011 Dec; 118(12):2442-6. PubMed ID: 21856016
[TBL] [Abstract][Full Text] [Related]
38. Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels.
Reuter M; Caswell CC; Lukomski S; Zipfel PF
J Biol Chem; 2010 Dec; 285(49):38473-85. PubMed ID: 20855886
[TBL] [Abstract][Full Text] [Related]
39. Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy.
Tortajada A; Gutiérrez E; Goicoechea de Jorge E; Anter J; Segarra A; Espinosa M; Blasco M; Roman E; Marco H; Quintana LF; Gutiérrez J; Pinto S; Lopez-Trascasa M; Praga M; Rodriguez de Córdoba S
Kidney Int; 2017 Oct; 92(4):953-963. PubMed ID: 28637589
[TBL] [Abstract][Full Text] [Related]
40. Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome.
Strobel S; Abarrategui-Garrido C; Fariza-Requejo E; Seeberger H; Sánchez-Corral P; Józsi M
Kidney Int; 2011 Aug; 80(4):397-404. PubMed ID: 21677636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
